BRPI0924418A2 - composições e métodos para a prevenção e o tratamento de obesidade e síndrome metabólica relacionada à obesidade - Google Patents
composições e métodos para a prevenção e o tratamento de obesidade e síndrome metabólica relacionada à obesidadeInfo
- Publication number
- BRPI0924418A2 BRPI0924418A2 BRPI0924418-2A BRPI0924418A BRPI0924418A2 BR PI0924418 A2 BRPI0924418 A2 BR PI0924418A2 BR PI0924418 A BRPI0924418 A BR PI0924418A BR PI0924418 A2 BRPI0924418 A2 BR PI0924418A2
- Authority
- BR
- Brazil
- Prior art keywords
- obesity
- treatment
- prevention
- present
- gastrointestinal tract
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title abstract 8
- 235000020824 obesity Nutrition 0.000 title abstract 8
- 230000002265 prevention Effects 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 208000001145 Metabolic Syndrome Diseases 0.000 title 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 241000894006 Bacteria Species 0.000 abstract 3
- 238000010521 absorption reaction Methods 0.000 abstract 3
- 230000000968 intestinal effect Effects 0.000 abstract 3
- 235000021588 free fatty acids Nutrition 0.000 abstract 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 2
- 208000030159 metabolic disease Diseases 0.000 abstract 2
- 241000186660 Lactobacillus Species 0.000 abstract 1
- 230000003579 anti-obesity Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 235000013376 functional food Nutrition 0.000 abstract 1
- 229940039696 lactobacillus Drugs 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 abstract 1
- 229960001243 orlistat Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 230000004580 weight loss Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
- Y10S435/854—Lactobacillus acidophilus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20090020474 | 2009-03-10 | ||
| KR10-2009-0020474 | 2009-03-10 | ||
| PCT/KR2009/003036 WO2010104242A1 (ko) | 2009-03-10 | 2009-06-05 | 미생물을 이용한 비만 및 비만으로 야기된 대사성 질환의 예방과 치료 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0924418A2 true BRPI0924418A2 (pt) | 2018-10-16 |
Family
ID=42728512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0924418-2A BRPI0924418A2 (pt) | 2009-03-10 | 2009-06-05 | composições e métodos para a prevenção e o tratamento de obesidade e síndrome metabólica relacionada à obesidade |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8986675B2 (pt) |
| EP (1) | EP2407170B1 (pt) |
| JP (1) | JP5665196B2 (pt) |
| KR (1) | KR101292714B1 (pt) |
| CN (1) | CN102438638B (pt) |
| BR (1) | BRPI0924418A2 (pt) |
| CA (1) | CA2755140A1 (pt) |
| MX (1) | MX2011009508A (pt) |
| WO (1) | WO2010104242A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6453534B2 (ja) * | 2012-09-28 | 2019-01-16 | 小林製薬株式会社 | 脂質代謝促進剤 |
| WO2015003001A1 (en) * | 2013-07-01 | 2015-01-08 | The Washington University | Methods for identifying supplements that increase gut colonization by an isolated bacterial species, and compositions derived therefrom |
| US10920283B2 (en) | 2013-11-01 | 2021-02-16 | Washington University | Methods to establish and restore normal gut microbiota function of subject in need thereof |
| KR102125548B1 (ko) * | 2015-02-10 | 2020-06-24 | 주식회사 지니스 | 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물 |
| KR102271821B1 (ko) * | 2020-12-18 | 2021-07-01 | 주식회사 엔테로바이옴 | 오를리스타트 및 아커만시아 뮤시니필라 eb-amdk19 균주를 포함하는 조성물 |
| WO2025163169A1 (en) * | 2024-02-01 | 2025-08-07 | Kerry Group Services International Limited | Probiotic composition for weight management |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0696537B2 (ja) * | 1986-05-02 | 1994-11-30 | 雪印乳業株式会社 | 血清コレステロ−ル上昇抑制剤 |
| US6080401A (en) * | 1998-11-19 | 2000-06-27 | Reddy; Malireddy S. | Herbal and pharmaceutical drugs enhanced with probiotics |
| JP4580542B2 (ja) * | 2000-05-17 | 2010-11-17 | 株式會社バイオニア | 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物 |
| KR20040027180A (ko) * | 2002-09-27 | 2004-04-01 | (주)바이오니아 | 비만 또는 당뇨병의 예방 및 치료 효과를 갖는 유산균발효 유제품 및 그 제조방법 |
| KR100543114B1 (ko) * | 2003-09-15 | 2006-01-20 | 주식회사한국야쿠르트 | 바실러스 서브틸리스 케이와이 912 |
| KR20050059860A (ko) * | 2003-12-15 | 2005-06-21 | 학교법인 경영교육재단 | 비만 예방 및 치료용 조성물 및 이의 용도 |
| SE529185C2 (sv) * | 2005-10-07 | 2007-05-22 | Arla Foods Amba | Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt |
| DK1981516T3 (en) * | 2006-01-27 | 2018-12-03 | Dupont Nutrition Biosci Aps | APPLICATION OF PROBIOTIC MICROORGANISMS FOR TREATMENT AND PREVENTION OF OBESIS AND RELATED DISORDERS |
| KR100851586B1 (ko) * | 2006-08-18 | 2008-08-12 | 이우정 | 락토바실러스를 유효성분으로 포함하는 비만 억제용 조성물 |
| JP2008214253A (ja) * | 2007-03-02 | 2008-09-18 | Snow Brand Milk Prod Co Ltd | 内臓脂肪減少剤 |
| JP2010534074A (ja) * | 2007-07-25 | 2010-11-04 | カンピナ ネーデルランド ホールディング ビー．ブイ． | 飽和および／または充足を誘発するプロバイオティックス |
-
2009
- 2009-06-05 BR BRPI0924418-2A patent/BRPI0924418A2/pt not_active Application Discontinuation
- 2009-06-05 EP EP09841555.7A patent/EP2407170B1/en not_active Not-in-force
- 2009-06-05 WO PCT/KR2009/003036 patent/WO2010104242A1/ko not_active Ceased
- 2009-06-05 JP JP2011553927A patent/JP5665196B2/ja active Active
- 2009-06-05 CN CN2009801591839A patent/CN102438638B/zh not_active Expired - Fee Related
- 2009-06-05 MX MX2011009508A patent/MX2011009508A/es active IP Right Grant
- 2009-06-05 US US13/255,838 patent/US8986675B2/en active Active
- 2009-06-05 CA CA2755140A patent/CA2755140A1/en not_active Abandoned
- 2009-06-05 KR KR1020117023816A patent/KR101292714B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120022764A (ko) | 2012-03-12 |
| US20120121753A1 (en) | 2012-05-17 |
| EP2407170B1 (en) | 2015-03-25 |
| WO2010104242A1 (ko) | 2010-09-16 |
| JP5665196B2 (ja) | 2015-02-04 |
| EP2407170A4 (en) | 2012-11-21 |
| KR101292714B1 (ko) | 2013-08-05 |
| US8986675B2 (en) | 2015-03-24 |
| CA2755140A1 (en) | 2010-09-16 |
| MX2011009508A (es) | 2011-10-24 |
| CN102438638B (zh) | 2013-12-18 |
| JP2012520292A (ja) | 2012-09-06 |
| EP2407170A1 (en) | 2012-01-18 |
| CN102438638A (zh) | 2012-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0924418A2 (pt) | composições e métodos para a prevenção e o tratamento de obesidade e síndrome metabólica relacionada à obesidade | |
| BR112012016982B8 (pt) | bactéria de ácido lático recombinante de grau alimentício e composição terapêutica | |
| WO2010081126A3 (en) | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin | |
| EA201790124A1 (ru) | Соли берберина, соли урсодезоксихолевой кислоты и их комбинации, способы получения и применения | |
| MX2014005433A (es) | Métodos y composiciones para modular bacterias gastrointestinales para promover la salud. | |
| WO2019066577A3 (ko) | 짧은 사슬 지방산 생성 장내 세균 군집의 변화를 이용한 알코올성 간 질환의 진단 및 치료용 조성물 | |
| WO2013103919A8 (en) | Compositions and methods for treating metabolic disorders | |
| WO2012036433A3 (ko) | miRNA를 타겟으로 한 신경퇴행성 질환 치료 | |
| JP2019500056A5 (pt) | ||
| MX354875B (es) | Composiciones y métodos para mejorar la función mitocondrial y tratar enfermedades neurodegenerativas y trastornos cognitivos. | |
| EA201391823A1 (ru) | Высушенные распылением штаммы/клетки лактобактерий и их применение против helicobacter pylori | |
| Li et al. | Polyphenolic extracts of coffee cherry husks alleviated colitis-induced neural inflammation via NF-κB signaling regulation and gut microbiota modification | |
| BR112017013465A2 (pt) | derivado de biarila, e, composição farmacêutica. | |
| RU2018121036A (ru) | Комбинированная пре- и пробиотическая композиция | |
| WO2014066053A3 (en) | Method of prevention and treatment of clostridium difficile infection | |
| WO2017022962A8 (ko) | Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
| EP4219714A3 (en) | Rna interference mediated inhibition of tmprss6 | |
| BR112013028709A2 (pt) | cepas bacterianas capazes de metabolizar oxalatos | |
| WO2018093238A3 (ko) | 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 | |
| WO2011038014A3 (en) | Composition and method for treatment of diabetes | |
| RU2016143195A (ru) | Применение lactobacilius rhamnosus для стимулирования восстановления разнообразия кишечной микробиоты после дисбактериоза | |
| WO2011087835A3 (en) | Novel compositions and methods for treating inflammatory bowel disease and airway inflammation | |
| BR112022007413A2 (pt) | Métodos para estimular a produção de um ou mais ácidos graxos, para inibir o crescimento de um ou mais filos bacterianos, para promover a saúde gastrointestinal, o crescimento de um ou mais filos bacterianos, a integridade da barreira intestinal e um fenótipo intestinal e para tratar ou prevenir doença de parkinson | |
| Chengfeng et al. | Engineered polyphenol-keratin nanocarriers enhance probiotic delivery and ameliorate obese ulcerative colitis | |
| EA201500181A1 (ru) | Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |